Strand Life Sciences, a subsidiary of Reliance Industries, has introduced CancerSpot, a blood-based test for early cancer ...
Research in biomedical laboratories has been changing significantly in recent years, to the point that test tubes have given ...
News Medical on MSN5d
Epigenetic profiles of blood cancer cells could aid in diagnosis and treatmentResearch in biomedical laboratories has been changing significantly in recent years, to the point that test tubes have given ...
This study examines the impact of DNA methylation on CTCF binding in two cancer cell lines. Increased CTCF binding sites are enriched in gene bodies, and associate with nuclear speckles, indicating a ...
The University of California system is putting nearly $6 million into research to help reduce cancer rates among firefighters ...
Health and Me on MSN3h
Researchers Launch CancerSpot-A Blood test That Could Detect Cancer Even Before Symptoms AppearStrand Life Sciences has introduced CancerSpot, a blood-based test designed for the early detection of multiple cancers. This ...
Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling technology for early detection of multiple cancers. The test aims to address the growing cancer burden in ...
Strand Life Sciences launches CancerSpot, a blood-based test for early cancer detection, using advanced methylation profiling ...
Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today ...
Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling for early detection of multiple ...
Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback